Proteas Bioanalytics Inc.

Phase 1 Clinical Trials > Clinical Sites

Diseases are predominately triggered not by heredity factors, but by the effects of sustained environmental and lifestyle factors on thousands of individual proteins. Proteas Bioanalytics has developed an innovative technological platform able to observe and quantify these proteins in a single human drop of blood quickly and effectively. This unique approach allows the minimally invasive detection of active disease and its response to treatment.

Contact

Spiros Garbis Founder, President, CEO/CTO Phone: 6262007238
Antigoni Manousopoulou CSO Phone: 6263458596
1124 West Carson Street MRL Building, 3rd Floor Torrance, CA 90502